The prognostic value of HPV infection and EGFR expression in head and neck cancers has been reported as HPV infections on the survival outcomes are identified as a better prognostic factor [33,34], and phosphorylated EGFR is associated with longer survival and as a potential therapeutic biomarker [35]. Here, EGFR is linked to head and neck cancer.